References
- Antoniou A, Pharoah P D, Narod S, et al (2003). Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet, 72, 1117-30. https://doi.org/10.1086/375033
- Bebbington Hatcher M, Fallowfield L J, (2003). A qualitative study looking at the psychosocial implications of bilateral prophylactic mastectomy. Breast, 12, 1-9. https://doi.org/10.1016/S0960-9776(02)00135-2
- Bjorkman B, Arner S, Hyden L C, (2008). Phantom breast and other syndromes after mastectomy: eight breast cancer patients describe their experiences over time: a 2-year follow-up study. J Pain, 9, 1018-25. https://doi.org/10.1016/j.jpain.2008.06.003
- Brandberg Y, Sandelin K, Erikson S, et al (2008). Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol, 26, 3943-9. https://doi.org/10.1200/JCO.2007.13.9568
- Bresser P J, Seynaeve C, Van Gool, et al (2006). Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women. Plast Reconstr Surg, 117, 1675-82. https://doi.org/10.1097/01.prs.0000217383.99038.f5
- Domchek S M, Friebel T M, Neuhausen S L, et al (2006). Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol, 7, 223-9. https://doi.org/10.1016/S1470-2045(06)70585-X
- DudokdeWit A C, Tibben A, Frets P G, et al (1997). BRCA1 in the family: a case description of the psychological implications. Am J Med Genet, 71, 63-71. https://doi.org/10.1002/(SICI)1096-8628(19970711)71:1<63::AID-AJMG12>3.0.CO;2-T
- Gill P S, Hunt J P, Guerra A B, et al (2004). A 10-year retrospective review of 758 DIEP flaps for breast reconstruction. Plast Reconstr Surg, 113, 1153-60. https://doi.org/10.1097/01.PRS.0000110328.47206.50
- Glaser B G, Strauss A L (1967). The discovery of grounded theory; strategies for qualitative research. Chicago,: Aldine Pub. Co.
- Hartmann L C, Schaid D J, Woods J E, et al (1999). Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med, 340, 77-84. https://doi.org/10.1056/NEJM199901143400201
- King M C, Marks J H, Mandell J B, Group N Y B C S (2003). Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science, 302, 643-6. https://doi.org/10.1126/science.1088759
- Kwong A, Wong C H, Shea C, Suen D T, Choi C L, (2010). Choice of management of southern Chinese BRCA mutation carriers. World J Surg, 34, 1416-26. https://doi.org/10.1007/s00268-010-0477-5
- Lerman C, Croyle R (1994). Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med, 154, 609-16. https://doi.org/10.1001/archinte.1994.00420060027003
- Lloyd S M, Watson M, Oaker G, et al (2000). Understandingthe experience of prophylactic bilateral mastectomy: a qualitative study of ten women. Psychooncology, 9, 473-85. https://doi.org/10.1002/1099-1611(200011/12)9:6<473::AID-PON490>3.0.CO;2-T
- Lodder L N, Frets P G, Trijsburg R W, et al (2002). One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat, 73, 97-112. https://doi.org/10.1023/A:1015269620265
- Marchettini P, Formaglio F, Lacerenza M (2001). Iatrogenic painful neuropathic complications of surgery in cancer. Acta Anaesthesiol Scand, 45, 1090-4. https://doi.org/10.1034/j.1399-6576.2001.450907.x
- Matlof E T, Shappell H, Brierley K, et al (2000). What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination. J Clin Oncol, 18, 2484-92. https://doi.org/10.1200/JCO.2000.18.12.2484
- McGaughey A (2006). Body image after bilateral prophylactic mastectomy: an integrative literature review. J Midwifery Womens Health, 51, 45-9. https://doi.org/10.1016/j.jmwh.2005.07.002
- Metcalfe K, Gershman S, Lynch H T, et al (2011). Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer, 104, 1384-92. https://doi.org/10.1038/bjc.2011.120
- Payne D K, Biggs C, Tran K N, Borgen P I, Massie M J (2000). Women's regrets after bilateral prophylactic mastectomy. Ann Surg Oncol, 7, 150-4. https://doi.org/10.1007/s10434-000-0150-6
- Reuben S S, Makari-Judson G, Lurie S D (2004). Evaluation of efficacy of the perioperative administration of venlafaxine XR in the prevention of postmastectomy pain syndrome. J Pain Symptom Manage, 27, 133-9. https://doi.org/10.1016/j.jpainsymman.2003.06.004
- Rothemund Y, Grüsser S M, Liebeskind U, Schlag P M, Flor H (2004). Phantom phenomena in mastectomized patients and their relation to chronic and acute pre-mastectomy pain. Pain, 107, 140-6. https://doi.org/10.1016/j.pain.2003.10.007
Cited by
- Contralateral prophylactic mastectomy in women with breast cancer: trends, predictors, and areas for future research vol.140, pp.3, 2013, https://doi.org/10.1007/s10549-013-2643-6
- genetic testing process vol.11, pp.1, 2014, https://doi.org/10.2217/pme.13.94
- Quality of Life and Psychological State in Chinese Breast Cancer Patients Who Received BRCA1/2 Genetic Testing vol.11, pp.7, 2016, https://doi.org/10.1371/journal.pone.0158531
- Differences in quality of life between American and Chinese breast cancer survivors vol.24, pp.9, 2016, https://doi.org/10.1007/s00520-016-3195-1
- Decision making for breast cancer prevention among women at elevated risk vol.19, pp.1, 2017, https://doi.org/10.1186/s13058-017-0826-5
- Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy vol.24, pp.2, 2017, https://doi.org/10.1245/s10434-016-5688-z
- The psychosocial impact of contralateral risk reducing mastectomy (CRRM) on women: A rapid review pp.10579249, 2017, https://doi.org/10.1002/pon.4448
- Knowledge Regarding and Patterns of Genetic Testing in Patients Newly Diagnosed With Breast Cancer Participating in the iCanDecide Trial pp.0008543X, 2018, https://doi.org/10.1002/cncr.31731
- Constructions of Decision Making for Risk-Reducing Mastectomy vol.28, pp.10, 2018, https://doi.org/10.1177/1049732318785372